Crossmark

Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity

Crossref DOI link: https://doi.org/10.1016/j.reumae.2016.07.004

Published Print: 2016-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Hernández-Flórez, Diana

Valor, Lara
License Information

Text and Data Mining valid from 2016-11-01
More Information

This article is maintained by: Elsevier

Article Title: Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2016.07.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2016.07.011

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.